Prescription Drug and Health Care Spending Reporting Requirements for Health Plans and Insurers Under the CAA-21 | Practical Law

Prescription Drug and Health Care Spending Reporting Requirements for Health Plans and Insurers Under the CAA-21 | Practical Law

A Practice Note addressing statutory requirements for group health plans and health insurers regarding prescription drug and health care spending under the Consolidated Appropriations Act, 2021 (CAA-21). The CAA-21 reporting requirements were the topic of implementing interim final regulations (IFRs) (addressed in this resource) that were issued by the federal administrative agencies in November 2021.

Prescription Drug and Health Care Spending Reporting Requirements for Health Plans and Insurers Under the CAA-21

by Practical Law Employee Benefits & Executive Compensation
Maintained • USA (National/Federal)
A Practice Note addressing statutory requirements for group health plans and health insurers regarding prescription drug and health care spending under the Consolidated Appropriations Act, 2021 (CAA-21). The CAA-21 reporting requirements were the topic of implementing interim final regulations (IFRs) (addressed in this resource) that were issued by the federal administrative agencies in November 2021.